Advertisement

Medikamentöse Behandlung der Depression im höheren Lebensalter

  • H.-J. Möller

Zusammenfassung

Es herrscht breite Übereinstimmung darüber, daß die medikamentöse Behandlung der Depression bei älteren Patienten im allgemeinen wirksam und sicher ist. Sie ist auch sehr wichtig, da die Depression zu den häufigsten psychiatrischen Erkrankungen des höheren Lebensalters gehört. Dennoeh bleibt ein hoher Prozentsatz der funktionellen Psychosen bei älteren Patienten unerkannt und unbehandelt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Altamura AC, Mauri MC, Colacurcio F, Scapicchio PL, Hadjchristos C, Carucci G, Minervini M, Montanini R, Perini M, Rudas N, et al. (1988) Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin. Psychopharmacology Berl 95 (Suppl): S 34–36Google Scholar
  2. 2.
    Braithwaite R (1982) Pharmacokinetics and age. In: Wheatley D (ed) Psychopharmacology of old age. Oxford University Press, Oxford, pp 46–54Google Scholar
  3. 3.
    Castleden CM, George CF, Marcer D, Hallett C (1977) Increased sensitivity to nitrazepam in old age. Br Med J 1:10–12PubMedCrossRefGoogle Scholar
  4. 4.
    Coffey DJ, Jenkyn LR, Coffey AK (1994) Effects of sertraline, amitriptyline and placebo on cognitive and motor functioning in the elderly: a double-blind crossover study. Presented a XlXth Collegium Internationale Neuropsychopharmacologicum; 27June-lJuly. Washington, DC, USAGoogle Scholar
  5. 5.
    Coffey DJ, Jenkyn LR, Richter EM (1994) A double-blind comparison of sertraline and nortriptyline in the treatment of depressed geriatric outpatients. Presented at the Vllth European College of Neuropsychopharmacology. 16–21 October. Jerusalem, IsraelGoogle Scholar
  6. 6.
    Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LF, Claghorn JL, Dessain EC, Itil TM, Lautin A (1990) Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 51 (Suppl B): 28–33PubMedGoogle Scholar
  7. 7.
    Crome P, Dawling S (1989) Pharmacokinetics of tricyclic and related antidepressants. In: Ghose K (ed) Antidepressants for elderly people. Chapman and Hall, London, pp 117–136Google Scholar
  8. 8.
    De Vanna M, Kummer J, Agnoli A, Gentili P, Lorizio A, Anand R (1990) Moclobemide compared with second-generation antidepressants in elderly people. Acta Psychiatr Scand (Suppl 360): 64–66CrossRefGoogle Scholar
  9. 9.
    Dunner DL (1994) Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry 55 (Suppl): 48–58PubMedGoogle Scholar
  10. 10.
    Dunner DL, Cohn JB, Walshe T, 3d, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC et al. (1992) Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 53 (Suppl): 57–60PubMedGoogle Scholar
  11. 11.
    Feighner JP, Cohn JB (1985) Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 46:20–25PubMedGoogle Scholar
  12. 12.
    Feighner JP, Boyer WF, Meredith CH, Hendrickson G (1988) An overview of fluoxetine in geriatric depression. Br J Psychiatry Suppl 105–108Google Scholar
  13. 13.
    Finkel SI, Richter EM (1995) Double-blind comparison of sertraline and nortriptyline in late-life depression. Presented at VHIth European College of Neuropsychopharmacology. 30 Sept.-4 Oct. Venice, ItalyGoogle Scholar
  14. 14.
    Gottfries CG, Karlsson I, Nyth AL (1992) Treatment of depression in elderly patients with and without dementia disorders. Int Clin Psychopharmacol 6 (Suppl 5): 55–64PubMedCrossRefGoogle Scholar
  15. 15.
    Halikas JA (1995) Org 3770 (Mirtazapin) versus trazodone: a placebo controlled trial in depressed elderly patients. Human Psychopharmacology 10:125–133CrossRefGoogle Scholar
  16. 16.
    Hampel H, Padberg F, Möller HJ, Berger C (1997) Pharmakotherapie älterer Patienten mit dem selektiven MAO-A-Inhibitor Moclobemid. Psychopharmakotherapie 4:1–11Google Scholar
  17. 17.
    Hegerl U, Möller HJ (1996) Nortriptylin. Psychopharmakotherapie 1:13–27Google Scholar
  18. 18.
    Hindmarch I (1992) A review of the psychomotor effects of paroxetine. Int Clin Psychopharmacol 6 (Suppl 4): 65–67PubMedCrossRefGoogle Scholar
  19. 19.
    Hoyberg OJ, Maragakis B, Mullin J, Norum D, Stordall E, Ekdahl P, Ose E, Moksnes KM, Sennef C (1996) A double-blind multicentre comparison of mirtazapin and amitriptyline in elderly depressed patients. Acta Psychiatr Scand 93:184–190PubMedCrossRefGoogle Scholar
  20. 20.
    McCue RE (1992) Using tricyclic antidepressants in the elderly. Clin Geriatr Med 8:323–334PubMedGoogle Scholar
  21. 21.
    Möller HJ (1991) Therapieresistenz auf Antidepressiva: Risikofaktoren und Behandlungs-möglichkeiten. Nervenarzt 62:658–669PubMedGoogle Scholar
  22. 22.
    Newhouse PA, Richter EM (1994) SSRI in depressed elderly: a double-blind comparison of sertraline and fluoxetine in depressed geriatric outpatients. Presented at VHIth European College of Neuropsychopharmacology; 16–21 Oct. Jerusalem, IsraelGoogle Scholar
  23. 23.
    Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134:790–793PubMedGoogle Scholar
  24. 24.
    Norman TR (1993) Pharmacokinetic aspects of antidepressant treatment in the elderly. Prog Neuropsychopharmacol Biol Psychiatry 17:329–344PubMedCrossRefGoogle Scholar
  25. 25.
    Phanjoo AL, Wonnacott S, Hodgson A (1991) Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand 83:476–479PubMedCrossRefGoogle Scholar
  26. 26.
    Plotkin DA, Gerson SC, Jarvik LF (1987) Antidepressant drug treatment in the elderly. In: Meltzer HY (ed) Psychopharmacology: The third generation of progress. Raven Press, New York, pp 1149–1158Google Scholar
  27. 27.
    Salzman C, Schneider LS, Alexopoulos G (1995) Treatment of depression in the elderly. In: Bloom F, Kupfer D (eds) Psychopharmacology: Fourth generation of progress. Raven Press, New York, pp 1471–1477Google Scholar
  28. 28.
    Schneider LS (1993) Efficacy of treatment for gerontopsychiatric patients with severe mental illness. Psychopharmacol Bull 29:501–524PubMedGoogle Scholar
  29. 29.
    Schneider LS, Olin JT (1995) Efficacy of acute treatment for geriatric depression. Int Psychogeriatr 7 (Suppl): 7–25PubMedCrossRefGoogle Scholar
  30. 30.
    Schöne W, Ludwig M (1993) A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 13:34S–39SPubMedGoogle Scholar
  31. 31.
    Sheldon JH (1963) The effects of age on the control a sway. Gerontol 5:129–138Google Scholar
  32. 32.
    Stewart RB (1993) Advances in pharmacotherapy: depression in the elderly - issues and advances in treatment. J Clin Pharm Ther 18:243–253PubMedCrossRefGoogle Scholar
  33. 33.
    Swift CG (1990) Pharmacodynamics: changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly. Br Med Bull 46:36–52PubMedGoogle Scholar
  34. 34.
    Swift CG, Ewen JM, Clarke P, Stevenson IH (1985) Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. Br J Clin Pharmacol 20:111–118PubMedGoogle Scholar
  35. 35.
    Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J (1984) Side-effect ’tolerance’ in elderly long-term recipients of benzodiazepine hypnotics. Age Ageing 13:335–343PubMedCrossRefGoogle Scholar
  36. 36.
    Swift CG, Swift MR, Ankier SI, Pidgen A, Robinson J (1985) Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. Br J Clin Pharmacol 20:119–128PubMedGoogle Scholar
  37. 37.
    Volz HP, Möller HJ (1994) Antidepressant drug therapy in the elderly - a critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry 27:93–100PubMedCrossRefGoogle Scholar
  38. 38.
    Volz HP, Müller H, Möller HJ (1995) Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression? Neuropsychobiology 32:23–30PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1997

Authors and Affiliations

  • H.-J. Möller

There are no affiliations available

Personalised recommendations